European Healthtech startup funding raised during February 2021.
In February 2021, 28 European Healthtech companies raised a combined €481M across 28 funding rounds, up 31.7% versus February 2020. UK led by capital raised, and Asabys Partners was the most active investor. Data as of 9 Jul 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Immunocore | Debt | Feb 2021 | €190M |
| Evox Therapeutics | Series C | Feb 2021 | €80M |
| Koa Health | Other | Feb 2021 | €30M |
| SpyBiotech | Series A | Feb 2021 |
3 exits · €70M disclosed.
| Ginolis | Acquisition | Feb 2021 | €70M |
| €27M |
| Highlight Therapeutics | Other | Feb 2021 | €23M |
| Sword Health | Series B | Feb 2021 | €21M |
| Medlumics | Other | Feb 2021 | €18M |
| Wren Therapeutics | Other | Feb 2021 | €14M |
| Theator | Series A | Feb 2021 | €13M |
| Founda Health | Seed | Feb 2021 | €12M |
| eConsult Health | Other | Feb 2021 | €8.0M |
| Virility Medical | Crowdfunding | Feb 2021 | €6.7M |
| AcuSurgical | Other | Feb 2021 | €5.8M |
| TokTokDoc | Other | Feb 2021 | €5.0M |
| EnginZyme | Other | Feb 2021 | €4.6M |
